Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease
Author:
Affiliation:
1. Interdisciplinary Brain Center for Clinical and Translational Research and Department of Neurology; Massachusetts General Hospital; Charlestown MA
2. Department of Biostatistics; Harvard T. H. Chan School of Public Health; Boston MA
Funder
Challenger Foundation
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.25280/fullpdf
Reference63 articles.
1. Alzheimer's disease research in the context of the national plan to address Alzheimer's disease;Snyder;Mol Aspects Med,2015
2. Comparative effectiveness and safety of cognitive enhancers for treating Alzheimer's disease: systematic review and network metaanalysis;Tricco;J Am Geriatr Soc,2018
3. Dimebon disappointment;Jones;Alzheimers Res Ther,2010
4. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials;Vandenberghe;Alzheimers Res Ther,2016
5. A phase 3 trial of semagacestat for treatment of Alzheimer's disease;Doody;N Engl J Med,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease;Alzheimer's & Dementia;2024-09-06
2. Virtual reality increases pressure pain threshold and lowers anxiety in children compared with control and non‐immersive control—A randomized, crossover trial;European Journal of Pain;2023-03-21
3. Single-Case Experimental Design in Rehabilitation;American Journal of Physical Medicine & Rehabilitation;2023-02-22
4. How to Perform N-of-1 Trials;The Japanese Journal of Rehabilitation Medicine;2022-11-18
5. Implementing the Care of Persons With Dementia in Their Environments (COPE) Intervention in Community-Based Programs: Acceptability and Perceived Benefit From Care Managers’ and Interventionists’ Perspectives;The Gerontologist;2022-05-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3